Please note: The license is valid for 12 months from the date the report is sent.
Needle-Free Delivery Technology – assess products, developments, and revenue prospects
What does the future hold for the needle-free delivery technology market? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.
Our 208 page report provides 97 tables, charts, and graphs covering 2 distinct submarket and 3 leading segments. Discover the most lucrative areas in the industry and the future market prospects. You will see financial results, interviews, trends, opportunities, and revenue predictions.Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT), company profiles and commercial developments. Read the full transcript of five exclusive expert opinion interviews with industry specialists informing your understanding and allowing you to assess prospects for investments and sales:
- Mr Mark Logomasini, Director of Business Development, Bioject Medical Technologies
- Mr David Hoey, CEO, Vaxxas
- Mr Chris Cappello, CTO, PharmaJet
- Dr D F Chowdhury, CEO, Nemaura
- Mr Robert E. Sievers, CEO and President, Aktiv-Dry LLC, and Professor, Department of Chemistry and Biochemistry, Center for Pharmaceutical Biotechnology, University of Colorado, BoulderYou will find prospects for key submarkets
In addition to analyses of the overall world market, you will see revenue forecasting of 2 major submarkets and 3 leading segments to 2025:
- Jet injectors
- Competing technologies
- Novel needle technology
- Inhaler technology
- Transdermal patch technology
Our new study also provides qualitative analyses for each submarket identifying strengths, weaknesses, opportunities and potential threats to sales growth.
How will those needle-free delivery technology markets expand? Which applications will generate most money? This study will allow you to thoroughly understand the industry, finding the most promising places for investments and sales.What are the prospects in the leading regions and countries?
Events and progress worldwide will influence the market.
In our study you will find individual revenue forecasts to 2025 for the leading regional and national markets:
Many opportunities exist within the needle-free delivery technology market. Greater uptake of existing technology and products worldwide will also stimulate the industry and market. With our new investigation you will gain business research and analysis with individual sales predictions and discussions. You will find analysis of competition, as well as commercial drivers and restraints. See what is likely to achieve the most success.Leading companies and potential for market growth
Overall world revenue for the needle-free delivery technology market will reach $1.2bn in 2015, our work forecasts. We predict strong revenue growth from 2015 to 2025. Our work shows you what organisations hold greatest potential. See profiles of 6 leading companies and others, including these:
- Antares Pharma
- Bioject Medical TechnologiesIn general, a company profile gives you the following information:
- Overview of the company, including its history in the needle-free delivery technology market
- Discussion of a company’s activities and outlook including descriptions of leading products
- Recent financial results
- Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborati
Get Industry Insights. Simply.
- Latest reports & slideshows with insights from top research analysts
- 60 Million searchable statistics with tables, figures & datasets
- More than 25,000 trusted sources